亚虹医药-U
(688176)
| 流通市值：42.44亿 | | | 总市值：55.63亿 |
| 流通股本：4.36亿 | | | 总股本：5.71亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 919,202,756.34 | 713,573,715.42 | 871,264,190.39 | 628,197,162.91 |
| 交易性金融资产 | 766,745,701.94 | 865,902,972.61 | 646,318,993.16 | 657,213,958.92 |
| 应收票据及应收账款 | 90,040,680.56 | 73,771,450.28 | 68,294,635.47 | 59,901,176.72 |
| 应收账款 | 90,040,680.56 | 73,771,450.28 | 68,294,635.47 | 59,901,176.72 |
| 预付款项 | 30,693,300.85 | 22,709,186.74 | 20,650,221.46 | 17,629,542.49 |
| 其他应收款合计 | 13,454,613.68 | 15,850,063.02 | 15,245,454.41 | 11,626,408.97 |
| 存货 | 11,738,356.57 | 9,735,896.97 | 7,157,335.8 | 5,837,584.88 |
| 一年内到期的非流动资产 | - | 151,893,082.2 | 151,201,232.88 | 150,539,583.32 |
| 流动资产合计 | 1,831,875,409.94 | 1,853,436,367.24 | 1,780,132,063.57 | 1,530,945,418.21 |
| 非流动资产: | | | | |
| 其他债权投资 | 93,827,833.74 | 93,220,381.68 | 152,678,632.83 | 453,764,749.66 |
| 其他权益工具投资 | 20,334,910.39 | 20,410,681.87 | 20,438,650.25 | 20,453,205.23 |
| 固定资产 | 23,800,188.49 | 25,256,031.28 | 26,669,477.82 | 28,320,738.66 |
| 使用权资产 | 48,441,750.45 | 49,252,985.72 | 53,126,811.08 | 57,129,831.3 |
| 无形资产 | 78,672,688.67 | 49,764,919.18 | 51,821,202.14 | 53,978,664.35 |
| 长期待摊费用 | 4,244,752.63 | 4,953,886.95 | 5,284,049.33 | 5,961,794.89 |
| 递延所得税资产 | 2,350,837.47 | 2,308,118.11 | 2,138,008.81 | 2,091,061.96 |
| 其他非流动资产 | 45,151,610.7 | 76,057,047.94 | 69,274,335.14 | 70,346,439.53 |
| 非流动资产合计 | 316,824,572.54 | 321,224,052.73 | 381,431,167.4 | 692,046,485.58 |
| 资产总计 | 2,148,699,982.48 | 2,174,660,419.97 | 2,161,563,230.97 | 2,222,991,903.79 |
| 流动负债: | | | | |
| 短期借款 | 260,985,966.9 | 200,079,945.54 | 107,855,747.67 | 66,246,159 |
| 应付票据及应付账款 | 28,579,815.41 | 40,301,081.92 | 35,126,942.58 | 49,544,619.95 |
| 应付账款 | 28,579,815.41 | 40,301,081.92 | 35,126,942.58 | 49,544,619.95 |
| 合同负债 | - | 265,925.73 | 242,151.87 | 306,405.76 |
| 应付职工薪酬 | 25,108,483.9 | 18,916,569.81 | 20,174,832.91 | 27,281,040.17 |
| 应交税费 | 6,265,962.16 | 3,821,984.68 | 4,214,843.54 | 5,782,957.71 |
| 其他应付款合计 | 30,233,026.04 | 34,199,408.27 | 36,882,664.37 | 31,567,950.85 |
| 一年内到期的非流动负债 | 16,124,247.86 | 15,145,551.24 | 16,705,304.68 | 16,330,697.32 |
| 流动负债合计 | 367,297,502.27 | 312,730,467.19 | 221,202,487.62 | 197,059,830.76 |
| 非流动负债: | | | | |
| 租赁负债 | 40,252,268.96 | 41,907,318.76 | 45,718,575.27 | 49,950,414.66 |
| 递延收益 | 4,943,537.02 | 5,164,977.97 | 5,386,418.92 | 5,607,859.87 |
| 非流动负债合计 | 45,195,805.98 | 47,072,296.73 | 51,104,994.19 | 55,558,274.53 |
| 负债合计 | 412,493,308.25 | 359,802,763.92 | 272,307,481.81 | 252,618,105.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 571,170,486 | 570,014,903 | 570,000,000 | 570,000,000 |
| 资本公积 | 2,906,232,194.46 | 2,895,059,686.63 | 2,888,592,532.42 | 2,883,617,895.78 |
| 减:库存股 | 50,059,352.74 | 50,059,352.74 | 50,059,352.74 | 50,059,352.74 |
| 其他综合收益 | -5,279,139.05 | -4,709,854.21 | -5,588,206.01 | -5,538,025.87 |
| 未分配利润 | -1,677,562,029.33 | -1,590,829,228.69 | -1,512,145,919.36 | -1,428,615,181.08 |
| 归属于母公司股东权益合计 | 1,744,502,159.34 | 1,819,476,153.99 | 1,890,799,054.31 | 1,969,405,336.09 |
| 少数股东权益 | -8,295,485.11 | -4,618,497.94 | -1,543,305.15 | 968,462.41 |
| 股东权益合计 | 1,736,206,674.23 | 1,814,857,656.05 | 1,889,255,749.16 | 1,970,373,798.5 |
| 负债和股东权益合计 | 2,148,699,982.48 | 2,174,660,419.97 | 2,161,563,230.97 | 2,222,991,903.79 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-30 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |